(Q61918476)

English

A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

An Open Label Pilot Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behavior Problems in Children and Adolescents With Autistic Spectrum Disorders (English)

0 references

medical condition

problem behavior

0 references

sponsor

Eli Lilly and Company

0 references

country

Netherlands

0 references

start time

February 2004

0 references

number of participants

12

0 references

research intervention

atomoxetine hydrochloride

0 references

clinical trial phase

phase IV clinical trial

0 references

research subject recruitment status

completed

0 references

minimum age

6 year

0 references

maximum age

17 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00485849

0 references

(Q61918476)

A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)